Topic archive

fda

10 stories

9/13/2026

Potential FDA approval of psychedelics impacts Japan

FDA approval of psychedelics like ibogaine could influence Japanese pharmacy practices.

9/10/2026

The FDA highlights its evolving approach to psychedelic therapies amid a mental health crisis.

9/8/2026

Jonathan Dickinson's new book explores ibogaine's therapeutic potential amid rising U.S. policy focus.

8/21/2026

Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.

8/20/2026

Nominee previously advocated for tighter controls on abortion medications.

8/19/2026

Heidi Overton's nomination could advance psychedelic therapies but raises vaccine concerns.

8/19/2026

Trump announces transfer of ibogaine investigational drug application to accelerate research.

8/7/2026

Psyence Biomedical outlines its focus on psychedelic therapeutics for mental health in a recent investor update.

7/24/2026

Psychoactive drug ibogaine gains attention for addiction treatment potential.

7/23/2026

Order encourages psychedelic research, allocates $50M for state studies.